Works by Ivy, Percy

Results: 89

Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute.

Published in:

Oncologist, 2021, v. 26, n. 10, p. e1883, doi. 10.1002/onco.13941

By:

Mittra, Arjun;
Naqash, Abdul Rafeh;
Murray, James H.;
Finnigan, Shanda;
Kwak‐Kim, Joanne;
Ivy, S. Percy;
Chen, Alice P.;
Sharon, Elad

Publication type:

Article

Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation.

Published in:

Oncologist, 2021, v. 26, n. 7, p. e1104, doi. 10.1002/onco.13758

By:

Kim, Joseph W.;
Cardin, Dana B.;
Vaishampayan, Ulka N.;
Kato, Shumei;
Grossman, Steven R.;
Glazer, Peter M.;
Shyr, Yu;
Ivy, S. Percy;
LoRusso, Patricia M.

Publication type:

Article

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer.

Published in:

Oncologist, 2019, v. 24, n. 9, p. 1149, doi. 10.1634/theoncologist.2019-0331

By:

Heath, Elisabeth;
Heilbrun, Lance;
Mannuel, Heather;
Liu, Glenn;
Lara, Primo;
Monk, J. Paul;
Flaig, Thomas;
Zurita, Amado;
Mack, Philip;
Vaishampayan, Ulka;
Stella, Philip;
Smith, Daryn;
Bolton, Susan;
Hussain, Arif;
Al‐Janadi, Anas;
Silbiger, Daniel;
Usman, Muhammad;
Ivy, S. Percy

Publication type:

Article

Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Brachytherapy in Puerto Rico After Hurricane Maria.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00414

By:

Kunos, Charles A.;
Ivy, Percy

Publication type:

Article

Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00180

By:

Kunos, Charles A.;
Capala, Jacek;
Finnigan, Shanda;
Smith, Gary L.;
Ivy, Susan Percy

Publication type:

Article

Radiopharmaceuticals for Relapsed or Refractory Leukemias.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00097

By:

Kunos, Charles A.;
Capala, Jacek;
Ivy, Susan Percy

Publication type:

Article

Triapine Radiochemotherapy in Advanced Stage Cervical Cancer.

Published in:

Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00149

By:

Kunos, Charles A.;
Ivy, S. Percy

Publication type:

Article

Notch1 phenotype and clinical stage progression in non-small cell lung cancer.

Published in:

Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-014-0104-2

By:

Nguyen, Dat;
Rubinstein, Larry;
Takebe, Naoko;
Miele, Lucio;
Tomaszewski, Joseph E.;
Ivy, Percy;
Doroshow, James H.;
Yang, Sherry X.

Publication type:

Article

Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas.

Published in:

Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-025-04778-5

By:

O'Sullivan Coyne, Geraldine;
Kummar, Shivaani;
Rubinstein, Larry V.;
Wilsker, Deborah;
Moore, Nancy;
Hogu, Murielle;
Piekarz, Richard;
Covey, Joe;
Beumer, Jan H.;
Ferry-Galow, Katherine V.;
Villaruz, Liza C.;
Hollingshead, Melinda G.;
Holleran, Julianne L.;
Deppas, Joshua J.;
Pommier, Yves;
Ko, Brian;
Johnson, Barry C.;
Parchhment, Ralph E.;
Ivy, Percy;
Doroshow, James H.

Publication type:

Article

Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 6, p. 815, doi. 10.1007/s00280-020-04176-z

By:

Do, Khanh T.;
O'Sullivan Coyne, Geraldine;
Hays, John L.;
Supko, Jeffrey G.;
Liu, Stephen V.;
Beebe, Kristin;
Neckers, Len;
Trepel, Jane B.;
Lee, Min-Jung;
Smyth, Tomoko;
Gannon, Courtney;
Hedglin, Jennifer;
Muzikansky, Alona;
Campos, Susana;
Lyons, John;
Ivy, Percy;
Doroshow, James H.;
Chen, Alice P.;
Shapiro, Geoffrey I.

Publication type:

Article

A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium.

Published in:

Oncologist, 2010, v. 15, n. 8, p. 810, doi. 10.1634/theoncologist.2010-0081

By:

TAYLOR, SARA K.;
CHIA, STEPHEN;
DENT, SUSAN;
CLEMONS, MARK;
AGULNIK, MARK;
GRENCI, PAMELA;
WANG, LISA;
OZA, AMIT M.;
IVY, PERCY;
PRITCHARD, KATHLEEN I.;
LEIGHL, NATASHA B.

Publication type:

Article

Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma.

Published in:

Leukemia & Lymphoma, 2012, v. 53, n. 5, p. 990, doi. 10.3109/10428194.2011.631236

By:

Oki, Yasuhiro;
Copeland, Amanda;
Romaguera, Jorge;
Fayad, Luis;
Fanale, Michelle;
Faria, Silvana de Castro;
Medeiros, L. Jeffrey;
Ivy, Percy;
Younes, Anas

Publication type:

Article

Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.

Published in:

Leukemia & Lymphoma, 2011, v. 52, n. 5, p. 833, doi. 10.3109/10428194.2011.555892

By:

Buckstein, Rena;
Kuruvilla, John;
Chua, Neil;
Lee, Christina;
Macdonald, David A.;
Al-tourah, Abdulwahab J.;
Foo, Alison H.;
Walsh, Wendy;
Percy ivy, S.;
Crump, Michael;
Eisenhauer, Elizabeth A.

Publication type:

Article

The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: A retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.

Published in:

Leukemia & Lymphoma, 2005, v. 46, n. 5, p. 681, doi. 10.1080/10428190500032612

By:

Olson, Douglas;
Taylor, Barbara;
La, Mei;
Sather, Harland;
Reaman, Gregory;
Ivy, S. Percy

Publication type:

Article

A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.

Published in:

Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 230, doi. 10.1002/pbc.24278

By:

Macy, Margaret E.;
Duncan, Tracey;
Whitlock, James;
Hunger, Stephen P.;
Boklan, Jessica;
Narendran, Aru;
Herzog, Cynthia;
Arceci, Robert J.;
Bagatell, Rochelle;
Trippett, Tanya;
Christians, Uwe;
Rolla, Katherine;
Ivy, S. Percy;
Gore, Lia

Publication type:

Article

Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker.

Published in:

2020

By:

Joshi, Anand;
Guo, Jianxia;
Holleran, Julianne L.;
Kiesel, Brian;
Taylor, Sarah;
Christner, Susan;
Parise, Robert A.;
Miller, Brian M.;
Ivy, S. Percy;
Chu, Edward;
Venkataramanan, Raman;
Beumer, Jan H.

Publication type:

journal article

Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies.

Published in:

2017

By:

Kunos, Charles;
Chu, Edward;
Beumer, Jan;
Sznol, Mario;
Ivy, S.;
Kunos, Charles A;
Beumer, Jan H;
Ivy, S Percy

Publication type:

journal article

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

Published in:

2012

By:

Brell JM;
Krishnamurthi SS;
Rath L;
Bokar JA;
Savvides P;
Gibbons J;
Cooney MM;
Meropol NJ;
Ivy P;
Dowlati A;
Brell, Joanna M;
Krishnamurthi, Smitha S;
Rath, Linda;
Bokar, Joseph A;
Savvides, Panayiotis;
Gibbons, Joseph;
Cooney, Matthew M;
Meropol, Neal J;
Ivy, Percy;
Dowlati, Afshin

Publication type:

journal article

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 4, p. 547, doi. 10.1007/s00280-012-1936-5

By:

Brell, Joanna;
Krishnamurthi, Smitha;
Rath, Linda;
Bokar, Joseph;
Savvides, Panayiotis;
Gibbons, Joseph;
Cooney, Matthew;
Meropol, Neal;
Ivy, Percy;
Dowlati, Afshin

Publication type:

Article

Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 1, p. 201, doi. 10.1007/s00280-012-1859-1

By:

Aregbe, Abdulateef;
Sherer, Eric;
Egorin, Merrill;
Scher, Howard;
Solit, David;
Ramanathan, Ramesh;
Ramalingam, Suresh;
Belani, Chandra;
Ivy, Percy;
Bies, Robert

Publication type:

Article

Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 4, p. 1021, doi. 10.1007/s00280-011-1798-2

By:

DuBois, Steven;
Shusterman, Suzanne;
Reid, Joel;
Ingle, Ashish;
Ahern, Charlotte;
Baruchel, Sylvain;
Glade-Bender, Julia;
Ivy, Percy;
Adamson, Peter;
Blaney, Susan

Publication type:

Article

Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients.

Published in:

2011

By:

Kolesar J;
Brundage RC;
Pomplun M;
Alberti D;
Holen K;
Traynor A;
Ivy P;
Wilding G;
Kolesar, Jill;
Brundage, Richard C;
Pomplun, Marcia;
Alberti, Dona;
Holen, Kyle;
Traynor, Anne;
Ivy, Percy;
Wilding, George

Publication type:

journal article

Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) in cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 393, doi. 10.1007/s00280-010-1331-z

By:

Kolesar, Jill;
Brundage, Richard;
Pomplun, Marcia;
Alberti, Dona;
Holen, Kyle;
Traynor, Anne;
Ivy, Percy;
Wilding, George

Publication type:

Article

The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 973, doi. 10.1007/s00280-010-1250-z

By:

Choi, Brian S.;
Alberti, Dona B.;
Schelman, William R.;
Kolesar, Jill M.;
Thomas, James P.;
Marnocha, Rebecca;
Eickhoff, Jens C.;
Ivy, S. Percy;
Wilding, George;
Holen, Kyle D.

Publication type:

Article

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 73, doi. 10.1007/s00280-009-1005-x

By:

Dowlati, Afshin;
Posey, James;
Ramanathan, Ramesh K.;
Rath, Linda;
Pingfu Fu;
Chak, Amitabh;
Krishnamurthi, Smitha;
Brell, Joanna;
Ingalls, Stephen;
Hoppel, Charles L.;
Ivy, Percy;
Remick, Scot C.

Publication type:

Article

Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 79, doi. 10.1007/s00280-008-0845-0

By:

Kolesar, Jill;
Wei Huang;
Eickhoff, Jens;
Hahn, Kristine;
Alberti, Dona;
Attia, Steven;
Schelman, William;
Holen, Kyle;
Traynor, Anne;
Ivy, Percy;
Wilding, George

Publication type:

Article

A phase I study of Triapine<sup>®</sup> in combination with doxorubicin in patients with advanced solid tumors.

Published in:

2009

By:

Schelman, William R.;
Morgan-Meadows, Sherry;
Marnocha, Rebecca;
Lee, Fred;
Eickhoff, Jens;
Wei Huang;
Pomplun, Marcia;
Zhisheng Jiang;
Alberti, Dona;
Kolesar, Jill M.;
Ivy, Percy;
Wilding, George;
Traynor, Anne M.

Publication type:

Report

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 851, doi. 10.1007/s00280-008-0807-6

By:

Brell, Joanna M.;
Krishnamurthi, Smitha S.;
Javle, Milind;
Saltzman, Joel;
Wollner, Ira;
Pelley, Robert;
Dowlati, Afshin;
Kantharaj, Belagodu N.;
Schluchter, Mark D.;
Rath, Linda;
Ivy, S. Percy;
Remick, Scot C.

Publication type:

Article

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 3, p. 441, doi. 10.1007/s00280-008-0754-2

By:

Krishnamurthi, Smitha S.;
Brell, Joanna M.;
Hoppel, Charles L.;
Egorin, Merrill J.;
Weaver, Karen C.;
Xiaolin Li;
Ingalls, Stephen;
Zuhowski, Eleanor T.;
Schluchter, Mark D.;
Dowlati, Afshin;
Cooney, Matthew M.;
Gibbons, Joseph;
Overmoyer, Beth A.;
Ivy, S. Percy;
Remick, Scot C.

Publication type:

Article

Phase I and pharmacokinetic study of the novel redox-active agent, motexafin gadolinium, with concurrent radiation therapy in patients with locally advanced pancreatic or biliary cancers.

Published in:

2006

By:

Ramanathan, Ramesh K.;
Fakih, Marwan;
Mani, Sridhar;
Deutsch, Melvin;
Perez, Raymond P.;
Ritter, Mark A.;
Eiseman, Julie L.;
Ivy, S. Percy;
Trump, Donald L.;
Belani, Chandra P.;
Parise, Robert A.;
Potter, Douglas M.;
Egorin, Merrill J.

Publication type:

journal article

Metabolic profile of XK469 (2( R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 351, doi. 10.1007/s00280-004-0962-3

By:

Anderson, Lawrence W.;
Collins, Jerry M.;
Klecker, Raymond W.;
Katki, Aspandiar G.;
Parchment, Ralph E.;
Boinpally, Ramesh R.;
LoRusso, Patricia M.;
Ivy, S. Percy

Publication type:

Article

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 3, p. 295, doi. 10.1007/s00280-004-0871-5

By:

Cooney, Matthew;
Tserng, Kou-Yi;
Makar, Vinit;
McPeak, R.;
Ingalls, Stephen;
Dowlati, Afshin;
Overmoyer, Beth;
McCrae, Keith;
Ksenich, Pamela;
Lavertu, Pierre;
Ivy, Percy;
Hoppel, Charles;
Remick, Scot

Publication type:

Article

Expanding access to early phase trials: the CATCH-UP.2020 experience.

Published in:

JNCI Cancer Spectrum, 2023, v. 7, n. 1, p. 1, doi. 10.1093/jncics/pkac087

By:

Baranda, Joaquina C;
Diaz, Francisco J;
Rubinstein, Larry;
Shields, Anthony F;
Dayyani, Farshid;
Mehta, Amitkumar;
Mehnert, Janice M;
Trent, Jonathan;
Mabaera, Rodwell;
Mooney, Margaret;
Moscow, Jeffrey A;
Doroshow, James;
Waters, Brittany;
Ivy, Percy;
Gore, Steven D;
Thomas, Alexandra

Publication type:

Article

Sunitinib malate in patients with intermediate-2 or high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 11, p. 2669, doi. 10.3109/10428194.2014.900763

By:

Yee, Karen W. L.;
Storring, John M.;
Buckstein, Rena;
Wells, Richard A.;
Xenocostas, Anargyros;
Kovacs, Michael J.;
Howson-Jan, Kang;
Wang, Eunice S.;
Battista, Kristina;
Wang, Lisa;
Oza, Amit M.;
Ivy, S. Percy;
Schuh, Andre C.

Publication type:

Article

Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints.

Published in:

Expert Opinion on Investigational Drugs, 2019, v. 28, n. 9, p. 771, doi. 10.1080/13543784.2019.1657403

By:

Ivy, S. Percy;
Kunos, Charles A.;
Arnaldez, Fernanda I.;
Kohn, Elise C.

Publication type:

Article

Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer.

Published in:

Expert Opinion on Investigational Drugs, 2016, v. 25, n. 5, p. 597, doi. 10.1517/13543784.2016.1156857

By:

Ivy, S. Percy;
Liu, Joyce F.;
Lee, Jung-Min;
Matulonis, Ursula A.;
Kohn, Elise C.

Publication type:

Article

Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors.

Published in:

Cancer (0008543X), 2023, v. 129, n. 12, p. 1904, doi. 10.1002/cncr.34730

By:

Mooradian, Meghan J.;
Cleary, James M.;
Giobbie‐Hurder, Anita;
Darville, Lancia N. F.;
Parikh, Aparna;
Buchbinder, Elizabeth I.;
Cohen, Justine V.;
Lawrence, Donald P.;
Shapiro, Geoffrey I.;
Keer, Harold;
Chen, Helen X.;
Ivy, Susan Percy;
Smalley, Keiran S. M.;
Koomen, John M.;
Sullivan, Ryan J.

Publication type:

Article

Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2012, v. 39, n. 4, p. 393, doi. 10.1007/s10928-012-9258-0

By:

Sherer, Eric;
Sale, Mark;
Pollock, Bruce;
Belani, Chandra;
Egorin, Merrill;
Ivy, Percy;
Lieberman, Jeffrey;
Manuck, Stephen;
Marder, Stephen;
Muldoon, Matthew;
Scher, Howard;
Solit, David;
Bies, Robert

Publication type:

Article

Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials.

Published in:

JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 11, p. 1437, doi. 10.1093/jnci/djac152

By:

Denicoff, Andrea M;
Ivy, S Percy;
Tamashiro, Tami T;
Zhao, Jinxiu;
Worthington, Katherine H;
Mooney, Margaret M;
Little, Richard F

Publication type:

Article

A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer.

Published in:

Breast Cancer Research & Treatment, 2012, v. 131, n. 3, p. 933, doi. 10.1007/s10549-011-1866-7

By:

Gartner, Elaina;
Silverman, Paula;
Simon, Michael;
Flaherty, Lawrence;
Abrams, Judith;
Ivy, Percy;
LoRusso, Patricia

Publication type:

Article

Oxaliplatin: a review of evolving concepts.

Published in:

2002

By:

Mani, Sridhar;
Graham, Martin A.;
Bregman, David B.;
Ivy, Percy;
Chaney, Stephen G.

Publication type:

journal article

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers.

Published in:

Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.01067

By:

Kunos, Charles A.;
Andrews, Stephen J.;
Moore, Kathleen N.;
Chon, Hye Sook;
Ivy, S. Percy

Publication type:

Article

Clinical Outcome Assessments Toolbox for Radiopharmaceuticals.

Published in:

Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.01028

By:

Kunos, Charles A.;
Capala, Jacek;
Dicker, Adam P.;
Movsas, Benjamin;
Ivy, Susan Percy;
Minasian, Lori M.

Publication type:

Article

Leveraging National Cancer Institute Programmatic Collaboration for Single Radiopharmaceutical Drug Master Files.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00573

By:

Kunos, Charles A.;
Capala, Jacek;
Ivy, Susan Percy

Publication type:

Article

Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00560

By:

Kunos, Charles A.;
Capala, Jacek;
Kohn, Elise C.;
Ivy, Susan Percy

Publication type:

Article

Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.

Published in:

Investigational New Drugs, 2022, v. 40, n. 1, p. 115, doi. 10.1007/s10637-021-01175-6

By:

Hubbard, Joleen M.;
Yin, Jun;
Schenk, Erin L.;
Qin, Rui;
Reid, Joel M.;
Strand, Carrie;
Fiskum, Jack;
Menefee, Michael;
Lin, Grace;
Doyle, L. Austin;
Ivy, Percy;
Erlichman, Charles;
Adjei, Alex;
Haluska, Paul;
Costello, Brian A.

Publication type:

Article

A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.

Published in:

2015

By:

LoConte, Noelle;
Razak, Albiruni;
Ivy, Percy;
Tevaarwerk, Amye;
Leverence, Rachael;
Kolesar, Jill;
Siu, Lillian;
Lubner, Sam;
Mulkerin, Daniel;
Schelman, William;
Deming, Dustin;
Holen, Kyle;
Carmichael, Lakeesha;
Eickhoff, Jens;
Liu, Glenn

Publication type:

Journal Article

A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.

Published in:

Investigational New Drugs, 2015, v. 33, n. 1, p. 169, doi. 10.1007/s10637-014-0166-6

By:

LoConte, Noelle;
Razak, Albiruni;
Ivy, Percy;
Tevaarwerk, Amye;
Leverence, Rachael;
Kolesar, Jill;
Siu, Lillian;
Lubner, Sam;
Mulkerin, Daniel;
Schelman, William;
Deming, Dustin;
Holen, Kyle;
Carmichael, Lakeesha;
Eickhoff, Jens;
Liu, Glenn

Publication type:

Article

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 1, p. 126, doi. 10.1007/s10637-009-9322-9

By:

Nock, Charles;
Brell, Joanna;
Bokar, Joseph;
Cooney, Matthew;
Cooper, Brenda;
Gibbons, Joseph;
Krishnamurthi, Smitha;
Manda, Sudhir;
Savvides, Panayiotis;
Remick, Scot;
Ivy, Percy;
Dowlati, Afshin

Publication type:

Article

Phase II study of sunitinib malate in head and neck squamous cell carcinoma.

Published in:

Investigational New Drugs, 2010, v. 28, n. 5, p. 677, doi. 10.1007/s10637-009-9296-7

By:

Choong, Nicholas;
Kozloff, Mark;
Taber, David;
Hu, H.;
Wade, James;
Ivy, Percy;
Karrison, Theodore;
Dekker, Allison;
Vokes, Everett;
Cohen, Ezra

Publication type:

Article